13F Holdings
中文EN

DCTH DELCATH SYSTEMS, INC.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 872912 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY38.1%
TTM net income YoY455.4%
TTM EPS YoY433.3%
Revenue 3-yr CAGR270.3%
Net income 3-yr CAGR—

Margins

Gross margin87.6%
Operating margin5.2%
Net margin6.1%
FCF margin18.3%
EBITDA margin5.6%

Returns

ROE5.4%
ROA4.9%
ROIC (approx.)5.6%
Asset turnover0.80x

Leverage & solvency

Liabilities / assets10.4%
Debt / equity0.00x
Current ratio10.87x
Interest coverage—

Cash quality & payout

Operating cash flow / net income3.46x
Accruals ratio-12.0%
Payout ratio—
Capex / revenue2.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$85.23M$37.20M$2.06M$2.72M$3.56M
Cost of revenue$11.80M$6.19M$635,000$686,000$671,000
Gross profit$73.43M$31.02M$1.43M$2.03M$2.88M
R&D expense$29.25M$13.87M$17.50M$18.58M$13.78M
SG&A expense$43.53M$29.55M$22.11M$17.30M$13.64M
Operating income$660,000-$12.41M-$38.18M-$33.85M-$24.53M
Pretax income$3.51M-$26.39M-$47.68M-$36.51M-$25.65M
Income tax$810,000$0$0$0$0
Net income$2.70M-$26.39M-$47.68M-$36.51M-$25.65M
EBITDA$898,000-$12.28M-$38.05M-$33.72M-$24.39M
EPS (basic)0.08-0.93-2.94-4.12-3.59
EPS (diluted)0.07-0.93-2.94-4.12-3.59
Weighted avg. shares (diluted)39.92M28.51M16.23M8.86M7.15M
Balance sheet
Cash & equivalents$43.45M$32.41M$12.65M$7.67M$22.80M
Short-term investments$47.58M$20.82M$19.81M$0—
Receivables$11.74M$10.89M$241,000$366,000$44,000
Inventory$10.25M$6.93M$3.32M$2.00M$1.41M
Current assets$119.53M$73.76M$37.16M$16.16M$31.15M
PP&E, net$3.17M$1.79M$1.35M$1.42M$1.35M
Total assets$123.63M$76.59M$38.61M$17.86M$33.12M
Current liabilities$10.95M$6.14M$16.45M$14.73M$5.95M
Long-term debt—$0$10.15M$15.69M—
Total debt—$0$10.15M$15.69M—
Total liabilities$12.41M$7.84M$22.84M$23.72M$21.17M
Shareholders' equity$111.22M$68.75M$15.78M-$5.86M$11.95M
Net debt—-$32.41M-$2.50M$8.02M—
Shares outstanding34.69M33.06M22.76M10.05M7.91M
Cash flow statement
Operating cash flow$22.52M-$18.68M-$31.25M-$24.95M-$22.60M
Capital expenditure$1.55M$559,000$58,000$209,000$143,000
Free cash flow$20.97M-$19.24M-$31.31M-$25.16M-$22.75M
Investing cash flow-$26.59M-$981,000-$19.71M-$209,000-$143,000
Financing cash flow$15.05M$39.41M$51.78M$10.14M$20.82M
Depreciation & amortization$238,000$134,000$128,000$132,000$146,000
Stock-based compensation$24.23M$9.77M$8.15M$7.94M—
Share buybacks$6.00M$0———

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.